Mapping the Landscape: What We Know (and Don’t Know) About Reducing Cannabis Harms
This cannabis harm reduction strategies review maps existing interventions without assessing their effectiveness. It highlights the fragmented evidence base and the need for rigorous trials. Clinicians should focus on biologically plausible risk…
Most European Countries Lack Evidence-Based Cannabis-Specific Treatment
Cannabis-specific treatment programs Europe remain limited and often lack evidence-based approaches. This 2025 overview reveals fragmented services with insufficient coverage. Structured psychosocial interventions are the most supported treatments for…
Treating Cyclic Vomiting and Cannabinoid Hyperemesis: Current Evidence and Expert Insights
Abortive therapy cyclic vomiting and cannabinoid hyperemesis are complex conditions requiring individualized treatment plans. This review highlights current evidence and expert opinion on abortive therapies. More research is needed to guide effective…
Cannabis and Mental Health: Why ‘It’s Complicated’ Is the Most Accurate Answer
This expert narrative review highlights cannabis mental health individual vulnerability as a key factor influencing outcomes. It explains how product type, cannabinoid composition, and personal risk profiles shape mental health effects. Understanding…
CBD’s Promise Outpaces Its Proof: A Comprehensive Review Finds Most Cannabis Products Lack Regulatory-Grade Evidence
CBD therapeutic development is advancing but regulatory-grade evidence remains limited. Most cannabis products lack robust clinical support beyond rare epilepsy syndromes. This review highlights the urgent need for rigorous trials and quality standards.
Cannabis Legalisation Linked to More Use Among Adults and More Emergency Harms—But Adolescent Use Appears Largely Unchanged
Paediatric cannabis poisoning increase is a significant concern after cannabis legalisation. Emergency department visits for poisoning have risen sharply, especially among children. Adult cannabis use has increased modestly, while adolescent use remains…
Cannabis and Sleep: A Proposed Vicious Cycle That Urgently Needs Testing
The bidirectional cannabis sleep model proposes that sleep problems lead to cannabis self-medication, which may worsen sleep quality over time. This cycle can increase cannabis tolerance and escalate use, raising the risk of cannabis use disorder.…
Only Five Trials Found: Cannabinoids for Post-Surgery Pain Remain an Open Question
The focus on cannabinoids acute postoperative pain reveals only five trials with contradictory results. This scarcity of data prevents meta-analytic evaluations and clinical recommendations. More standardized research is essential to clarify their role…
What Does the Evidence Really Say About Cannabis Risks and Medical Benefits?
The cannabis health risks medical benefits evidence review 2024 synthesizes global research on recreational cannabis harms and medicinal benefits. It highlights adolescent vulnerability and modest medicinal efficacy. This review guides clinicians on…
First Systematic Typology of Cannabis Harm Reduction Strategies Maps a Fragmented Field
This 2024 scoping review presents a cannabis harm reduction typology that classifies legal, organizational, and health-related strategies. It highlights the fragmented field and the lack of effectiveness data. The typology provides a foundation for…